Revealing the Strong Functional Association of adipor2 and cdh13 with adipoq: A Gene Network Study

Cell Biochemistry and Biophysics

Volumn 71, Issue 3, 2015, Pages 1445-1456

  Bag, Susmita ^a   Anbarasu, Anand ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Adipoq; Adipor2; Cdh13; Gene networks; Obesity

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPOR2 PROTEIN, HUMAN; CADHERIN; H-CADHERIN;

BIOLOGY; GENE REGULATORY NETWORK; GENETIC ASSOCIATION STUDY; GENETICS; HUMAN; OBESITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; CADHERINS; COMPUTATIONAL BIOLOGY; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; HUMANS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN;

EID: 84930084302     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0367-9     Document Type: Article

References (78)

1. Segal, E., et al. (2005). From signatures to models: Understanding cancer using microarrays. Nature Genetics,37, 38–45.
2. Bernardo, D. D., et al. (2005). Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. National Biotechnology,23(3), 377–383.
3. Gardner, T. S., et al. (2003). Inferring genetic networks and identifying compound mode of action via expression profiling. Science,301(5629), 102–105.
4. Calvano, S. E., et al. (2005). A network-based analysis of systemic inflammation in humans. Nature,437(7061), 1032–1037.
5. Jiang, W., Li, X., et al. (2008). Constructing disease-specific gene networks using pair-wise relevance metric: Application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements. BMC Systems Biology,2, 72.
6. Anitha, P., et al. (2014). Computational gene network study on antibiotic resistance genes of Acinetobacter baumannii. Computers in Biology and Medicine,48, 17–27.
7. Hayasaka, S., Hugenschmidt, C. E., & Laurienti, P. J. (2011). A network of genes, genetic disorders, and brain areas. PLoS ONE,6(6), e20907.
8. Jacob, F., & Monod, J. (1961). Genetic regulatory mechanisms in the synthesis of proteins. Journal of Molecular Biology,3, 318–356.
9. Franke, L., et al. (2006). Reconstruction of a functional human gene network, with an application for prioritizing positional candidate genes. American Journal of Human Genetics,78, 1011–1025.
10. Xenarios, I., Rice, D. W., et al. (2000). DIP: The database of interacting proteins. Nucleic Acids Research,28(1), 289–291.
11. Alfarano, C., Andrade, C. E., et al. (2005). The biomolecular interaction network database and related tools 2005 update. Nucleic Acids Research,33, 418–424.
12. Chatr Aryamontri, A., Breitkreutz, B. J., et al. (2013). The BioGRID interaction database: 2013 update. Nucleic Acids Research,41, 816–823.
13. Keshava, P. T. S., Goel, R., et al. (2009). Human protein reference database—2009 update. Nucleic Acids Research,37(1), 767–772.
14. Kerrien, S., Aranda, B., et al. (2012). The IntAct molecular interaction database in 2012. Nucleic Acids Research,40(D1), 841–846.
15. WHO. (2000). The problem of overweight and obesity. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation. WHO Technical Report Series, Series 894 (pp. 5–37).
16. Zimmet, P. Z., & Alberti, K. G. (2006). Introduction: Globalization and the non-communicable disease epidemic. Obesity (Silver Spring),14(1), 1–3.
17. Qi, L., & Cho, Y. A. (2008). Gene–environment interaction and obesity. Nutrition Reviews,66(12), 684–694.
18. Ogden, C. L., Yanovski, S. Z., et al. (2010). The epidemiology of obesity. Gastroenterology,39(1), 1–7.
19. Hu, E., Liang, P., et al. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry,271(18), 10697–10703.
20. Belahsen, R., Bermudez, O. I., et al. (2005). Obesity and related metabolic disorders are prevalent in Moroccan women of child-bearing age. International Journal of Diabetes and Metabolism,13, 159–166.
21. Enns, J. E., Taylor, C. G., et al. (2011). Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: The modulatory role of gene–nutrient interactions. Journal of Obesity,2011(2011), 1–17.
22. Grundy, S. M. (2004). Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology and Metabolism,89, 2595–2600.
23. Sharma, A. M. (2002). Adipose tissue: A mediator of cardiovascular risk. International Journal of Obesity and Related Metabolic Disorder,26(4), 5–7.
24. Klaus, S. (2004). Adipose tissue as a regulator of energy balance. Current Drug Targets,5, 241–250.
25. Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal Nutrition,92, 347–355.
26. Kyriakou, T., Collins, L. J., Spencer-Jones, N. J., Malcolm, C., Wang, X., Snieder, H., et al. (2008). Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. Journal of Human Genetics,53(8), 718–727.
27. Valle, M., et al. (2005). Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome. Diabetes and Metabolism,31(1), 55–62.
28. Comuzzie, A. G., et al. (2001). The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism,86, 4321–4325.
29. Kissebah, A. H., Sonnenberg, G. E., Myklebust, J., et al. (2000). Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proceedings of the National Academy of Sciences,97, 14478–14483.
30. Snel, B., Lehmann, G., et al. (2000). STRING: A web-server to retrieve and display the repeatedly occurring neighbourhood of a gene. Nucleic Acids Research,28, 3442–3444.
31. Von Mering, C., Huynen, M., et al. (2003). STRING: A database of predicted functional associations between proteins. Nucleic Acids Research,31, 258–261.
32. Von Mering, C., Jensen, L. J., et al. (2005). STRING: Known and predicted protein–protein associations integrated and transferred across organisms. Nucleic Acids Research,33, 433–437.
33. Von Mering, C., Jensen, L. J., et al. (2007). STRING 7—Recent developments in the integration and prediction of protein interactions. Nucleic Acids Research,35, 358–362.
34. Jensen, L. J., Kuhn, M., et al. (2009). STRING 8—A global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Research,37, 412–416.
35. Szklarczyk, D., et al. (2011). The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Research,39, 561–568.
36. Warde-Farley, D., et al. (2010). The GeneMANIA prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acids Research,38, 214–220.
37. Kanehisa, M., et al. (2004). The KEGG resource for deciphering the genome. Nucleic Acids Research,32, 277–280.
38. Croft, D., et al. (2010). Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Research,39, 691–697.
39. Datta, S., et al. (2009). Computational biology touches all bases. Genome Biology,10(2), 303.
40. Cowley, M. J., et al. (2012). PINA v2.0: Mining interactome modules. Nucleic Acids Research,40, 862–865.
41. Martin, A., et al. (2010). BisoGenet: A new tool for gene network building, visualization and analysis. BMC Bioinformatics,10, 91.
42. Lee, I., et al. (2011). Prioritizing candidate disease genes by network-based boosting of genome-wide association data. Genome Research,21(7), 1109–1121.
43. Shannon, P., et al. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research,13(11), 2498–2504.
44. Peng, Y., et al. (2006). SNPs3D: Candidate gene and SNP selection for association studies. BMC Bioinformatics,7, 166.
45. Li, J., et al. (2009). Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology,5, 1–15.
46. Yamauchi, T., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature,423(6941), 762–769.
47. Neumeier, M., et al. (2005). Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors. Biochemical and Biophysical Research Communications,334(3), 924–929.
48. Kuroyanagi, K., et al. (2008). Citrus auraptene acts as an agonist for PPARs and enhances adiponectin production and MCP-1 reduction in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications,366(1), 219–225.
49. Hug, C., et al. (2004). T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proceeding of National Academy of Sciences U S A,101(28), 10308–10313.
50. Monda, K. L., et al. (2010). The genetics of obesity and the metabolic syndrome. Endocrine, Metabolic and Immune Disorders Drug Targets,10(2), 86–108.
51. Awazawa, M., et al. (2009). Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway. Biochemical and Biophysical Research Communications,382(1), 51–56.
52. Park, B. H., et al. (2004). Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes. Molecular Cell Biology,24(19), 8671–8680.
53. Kern, P. A., et al. (2004). Perilipin expression in human adipose tissue is elevated with obesity. Journal of Clinical Endocrinology and Metabolism,89(3), 1352–1358.
54. Mao, X., et al. (2006). APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nature Cell Biology,8(5), 516–523.
55. Morínigo, R., et al. (2006). Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obesity Surgery,16(6), 745–751.
56. Miyoshi, H., et al. (2010). Perilipin overexpression in mice protects against diet-induced obesity. Journal of Lipid Research,51(5), 975–982.
57. Garvey, W. T., et al. (1992). Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes,41(4), 465–475.
58. Loo, L. H., Lin, H. J., Singh, D. K., et al. (2009). Heterogeneity in the physiological states and pharmacological responses of differentiating 3T3-L1 preadipocytes. Journal of Cell Biology,187(3), 375–384.
59. Ceddia, R. B., Somwar, R., Maida, A., et al. (2005). Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia,48(1), 132–139.
60. Terra, X., et al. (2011). FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women. European Journal of Endocrinology,164(4), 539–547.
61. Dobrian, A. D. (2006). The complex role of PPARgamma in renal dysfunction in obesity: Managing a Janus-faced receptor. Vascular Pharmacology,45(1), 36–45.
62. Gregoire, F. M., et al. (1998). Understanding adipocyte differentiation. Physiological Reviews,78(3), 783–809.
63. Sato, M., Mori, Y., et al. (1998). The H-cadherin (CDH13) gene is inactivated in human lung cancer. Human Genetics,103(1), 96–101.
64. Kola, B., et al. (2008). The role of AMP-activated protein kinase in obesity. Frontiers of Hormone Research,36, 198–211.
65. Pruitt, K., et al. (2006). Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genetics,2(3), 0344–0352.
66. Kadowaki, T., et al. (2006). Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation,116(7), 1784–1792.
67. Körner, A., et al. (2007). Total and high-molecular-weight adiponectin in breast cancer: In vitro and in vivo studies. Journal of Clinical Endocrinology and Metabolism,92(3), 1041–1048.
68. Spyridopoulos, T. N., et al. (2007). Low adiponectin levels are associated with renal cell carcinoma: A case-control study. International Journal of Cancer,120(7), 1573–1578.
69. Broedl, U. C., et al. (2009). Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS ONE,4(3), e4733.
70. Mistry, T., et al. (2006). The regulation of adiponectin receptors in human prostate cancer cell lines. Biochemical and Biophysical Research Communications,348(3), 832–838.
71. Kotronen, A., et al. (2009). Genetic variation in the ADIPOR2 gene is associated with liver fat content and its surrogate markers in three independent cohorts. European Journal of Endocrinology,160(4), 593–602.
72. Kremmidiotis, G., et al. (1998). Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity. Genomics,49(3), 467–471.
73. Widschwendter, A., et al. (2004). CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients. International Journal of Cancer,109(2), 163–166.
74. Kim, D. S., et al. (2007). Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer,110(12), 2785–2792.
75. Brock, M. V., et al. (2008). DNA methylation markers and early recurrence in stage I lung cancer. The New England Journal of Medicine,358(11), 1118–1128.
76. Shinichi, T., et al. (2002). Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas. Cancer Research,62(12), 3382–3386.
77. Hibi, K., et al. (2004). CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. British Journal of Cancer,90(5), 1030–1033.
78. Matuschek, C., et al. (2010). Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease. European Journal of Medical Research,15, 277–286.